Accf/hrs/aha/ase/hfsa/scai/scct/scmr 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: A report of the …
AM Russo, RF Stainback, SR Bailey, AE Epstein… - Journal of the American …, 2013 - jacc.org
Abstract The American College of Cardiology Foundation in collaboration with the Heart
Rhythm Society and key specialty and subspecialty societies conducted a review of common …
Rhythm Society and key specialty and subspecialty societies conducted a review of common …
A systematic review of ICD complications in randomised controlled trials versus registries: is our 'real-world'data an underestimation?
VA Ezzat, V Lee, S Ahsan, AW Chow, O Segal… - Open …, 2015 - openheart.bmj.com
Implantable cardioverter defibrillator (ICD) implantation carries a significant risk of
complications, however published estimates appear inconsistent. We aimed to present a …
complications, however published estimates appear inconsistent. We aimed to present a …
Complications after cardiac implantable electronic device implantations: an analysis of a complete, nationwide cohort in Denmark
RE Kirkfeldt, JB Johansen, EA Nohr… - European heart …, 2014 - academic.oup.com
Aims Complications after cardiac implantable electronic device (CIED) treatment, including
permanent pacemakers (PMs), cardiac resynchronization therapy devices with defibrillators …
permanent pacemakers (PMs), cardiac resynchronization therapy devices with defibrillators …
Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE …
JE Poole, MJ Gleva, T Mela, MK Chung, DZ Uslan… - Circulation, 2010 - Am Heart Assoc
Background—Prospective studies defining the risk associated with pacemaker or
implantable cardioverter-defibrillator replacement surgeries do not exist. These procedures …
implantable cardioverter-defibrillator replacement surgeries do not exist. These procedures …
[HTML][HTML] Prospective blinded evaluation of a novel sensing methodology designed to reduce inappropriate shocks by the subcutaneous implantable cardioverter …
DAMJ Theuns, TF Brouwer, PW Jones, V Allavatam… - Heart Rhythm, 2018 - Elsevier
Background Most inappropriate shocks from the subcutaneous implantable cardioverter-
defibrillator (S-ICD) are caused by cardiac oversensing. A novel sensing methodology …
defibrillator (S-ICD) are caused by cardiac oversensing. A novel sensing methodology …
HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in …
The implantable cardioverter defibrillator (ICD) has emerged as an important treatment
option for selected patients who are at risk of sudden cardiac death. Randomized trials have …
option for selected patients who are at risk of sudden cardiac death. Randomized trials have …
Rates of and factors associated with infection in 200 909 Medicare implantable cardioverter-defibrillator implants: results from the National Cardiovascular Data …
JM Prutkin, MR Reynolds, H Bao, JP Curtis… - Circulation, 2014 - Am Heart Assoc
Background—The rate of implantable cardioverter-defibrillator (ICD) infections has been
increasing faster than that of implantation. We sought to determine the rate and predictors of …
increasing faster than that of implantation. We sought to determine the rate and predictors of …
[HTML][HTML] Subcutaneous implantable cardioverter-defibrillator post-approval study: clinical characteristics and perioperative results
MR Gold, JD Aasbo, MF El-Chami, M Niebauer, J Herre… - Heart rhythm, 2017 - Elsevier
Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed
to reduce short-and long-term complications associated with transvenous ICD leads. Early …
to reduce short-and long-term complications associated with transvenous ICD leads. Early …
The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy
C O'Mahony, PD Lambiase, G Quarta, M Cardona… - Heart, 2012 - heart.bmj.com
Objective Implantable cardioverter defibrillators (ICDs) are routinely used to prevent sudden
cardiac death (SCD) in selected hypertrophic cardiomyopathy (HCM) patients, but the …
cardiac death (SCD) in selected hypertrophic cardiomyopathy (HCM) patients, but the …
Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR …
TA Dewland, CN Pellegrini, Y Wang, GM Marcus… - Journal of the American …, 2011 - jacc.org
Objectives: The aim of this study was to compare single-versus dual-chamber implantable
cardioverter-defibrillator (ICD) implantation and complication rates in a large, real-world …
cardioverter-defibrillator (ICD) implantation and complication rates in a large, real-world …